AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2014
Dec 22, 2014
34129_dirs_2014-12-22_50595726-02e6-40dd-a697-bc67f37e89d0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2014-12-18
Reporting Person: Stein Kathryn E (SVP, Product Dev. & Regulatory)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-18 | Common Stock | M | 10946 | $0.71 | Acquired | 54151 | Direct |
| 2014-12-18 | Common Stock | S | 10946 | $33.00 | Disposed | 43205 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-18 | Employee Stock Option (right to buy) | $0.71 | M | 10946 | Disposed | 2016-03-23 | Common Stock (10946) | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 30, 2014.
F2: The price reported in Column 4 is a weighted average price.
More from MACROGENICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 13
Merger & Acquisition
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18